Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with ...
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
devdiscourse29m
Wall Street Wavers Amid Federal Rate Concerns and Holiday Trading
U.S. stock markets experienced fluctuations as investors reacted to potential changes in Federal Reserve rate cuts.
S&P 500, Dow dip in choppy trading at start of holiday-shortened week
The S&P 500 and the Dow fell on Monday in holiday-thinned trading after a stopgap government funding bill averted a U.S.